A pilot trial for ozanimod therapy in hospitalized COVID-19 patients
D. Marsolais (Quebec, Canada), N. Châteauvert (Quebec, Canada), P. Blais-Lecours (Quebec, Canada), P. Rola (Montreal, Canada), T. Nguyen (Laval, Canada), F. Lellouche (Quebec, Canada)
Source: International Congress 2022 – COVID-19: from bench to bedside
Session: COVID-19: from bench to bedside
Session type: Thematic Poster
Number: 3530
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Marsolais (Quebec, Canada), N. Châteauvert (Quebec, Canada), P. Blais-Lecours (Quebec, Canada), P. Rola (Montreal, Canada), T. Nguyen (Laval, Canada), F. Lellouche (Quebec, Canada). A pilot trial for ozanimod therapy in hospitalized COVID-19 patients. 3530
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|